Prevalencia serológica del virus de influenza A en cerdos en Argentina durante la temporada 2002: evaluación mediante inhibición de la hemaglutinación y ELISA / Seroprevalence of the swine Influenza virus in fattening pigs in Argentina in the 2002 season: evaluation by hemagglutination-inhibition and ELISA tests

Se evaluó la prevalencia serológica del virus de influenza mediante las pruebas de inhibición de la hemaglutinación (IHA) y ELISA para los subtipos H1N1 y H3N2 en 13 granjas porcinas de Argentina. Se compararon los resultados obtenidos mediante ambas pruebas en términos individuales y de establecimientos. La prevalencia individual por la técnica de IHA fue de 38,46% a 100% para H1 y de 7,69% a 100% para H3. Por la técnica de ELISA, la prevalencia individual fue de 2,33% a 6,9% para H1 y de 9,65% a 48% para H3. No se observaron diferencias significativas entre ambas técnicas a escala de granja (H1: p=0,20; H3: p=0,11). La concordancia entre las pruebas fue nula al tomar como unidad de referencia el animal (H1: 0,005; H3: 0,070), mientras que en términos de establecimiento fue escasa (H1: 0,350; H3: 0,235). Considerando la alta prevalencia individual obtenida por la prueba de IHA y la alta sensibilidad de esta técnica, se podría sugerir que en las poblaciones porcinas de la Argentina circularon cepas virales humanas o cepas porcinas con gran proximidad filogenética a las utilizadas en este estudio desde el año 2002.

The seroprevalence of the Influenza virus against H1N1 and H3N2 was determined by the hemagglutination-inhibition test (HI) and a commercial swine influenza ELISA kit, in 13 Argentinean swine herds. The results of within-herd and between-herd prevalence obtained by both tests were statistically correlated. The within-herd prevalence observed by the HI test varied from 38.46 to 100% against H1 and 7.69 to 100% for H3. When the within-herd prevalence was measured with the ELISA test, it varied from 2.33 to 6.9% for H1 and 9.65 to 48% for H3. No statistical differences were observed at herd level between HI and ELISA (H1: p = 0. 20; H3: p=0.11). No agreement between HI and ELISA detected prevalence was observed when the within-herd prevalence was compared (H1: 0.005; H3: 0.070), while the agreement at herd level was considered poor (H1: 0,350; H3: 0,235). The high within-herd prevalence values observed with the HI test and the high sensibility of this test might show that human strains or swine strains phylogenetically closely related to the humans strains used in the HI test in this study have been affecting the swine population since 2002.

La prevención de la influenza: recomendaciones para la temporada de 2005-2006 / Preventing influenza: recommendations for the 2005-2006 season

Influenza is a serious health problem worldwide due to the epidemics and pandemics that it periodically causes. The Advisory Committee on Immunization Practices (ACIP) of the United States of America recently published updated recommendations for influenza prevention and control for the 2005-2006 season. Many of these guidelines are of interest to the countries of the Region of the Americas, particularly those related to vaccination, which is the mainstay for preventing and controlling this disease. Various changes have been made in the recommendations that were published in 2004. First, the ACIP recommends vaccination against influenza for persons with any condition (e.g., cognitive dysfunction, spinal cord injury, seizure disorder, or other neuromuscular disorder) that can compromise respiratory function or make eliminating respiratory secretions difficult or that can increase the risk for aspiration. Second, the ACIP strongly recommends that all health care workers be vaccinated against influenza annually and encourages facilities that employ health care workers to vaccinate them by using approaches that maximize immunization rates. Third, the ACIP encourages the use of both available vaccines (inactivated and live, attenuated influenza vaccine (LAIV)) for eligible persons every influenza season, especially persons in recommended target groups. When inactivated virus vaccine is in short supply, the use of LAIV is especially encouraged, if feasible, for eligible persons (including health care workers) because such use might considerably increase the availability of inactivated virus vaccine for persons in high-risk groups. Fourth, the 2005-06 trivalent vaccine virus strains are A/California/7/2004 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Shanghai/361/2002-like antigens. For the A/California/7/2004 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/ New York/55/2004 virus, and for the B/Shanghai/361/2002-like antigen, manufacturers may use the antigenically equivalent B/Jilin/20/2003 virus or B/Jiangsu/10/2003 virus.

Isolation of recent variant influenza types A(H3N2), A (H1N1) & B strains in Pune, India.

A total of 293 patients with influenza like illness were investigated during the course of continuous surveillance on influenza in Pune, India in 2000. The throat/nasal swab specimens collected from these patients were inoculated in MDCK cell culture and influenza types A(H3N2), A(H1N1) and type B strains were isolated. They were identified as similar to the recently prevalent variant strains; A/Sydney/05/97(H3N2), A/New Caledonia/20/99(H1N1) and B/Sichuan/379/99. The latter two were the new variant strains reported for the first time in Pune. It is important to note that A(H1N1) strains were isolated in Pune during 2000 after a gap of 10 yr.

Hemagglutinating and sialidase activities of subpopulations of influenza A viruses

The present study was conducted to investigate the characteristics of two samples of influenza A/England/42/72 (H3N2) virus, one of them selected by an adsorption-elution technique, to determine the possible existence of virus variants or subpopulations. Based on specificity of virulence-related cell receptor-binding and sialidase activities, this selection technique using human O group erythrocytes revealed the presence of variants within a standard virus sample with diversity for their hemagglutinating and sialidase activities. The standard-like (E1) sample exhibited titers of 4 and 32 HAU (hemagglutinating units in 25 microliters) with human O group and chicken erythrocytes, respectively, while the sample obtained by the adsorption-elution process (E2) exhibited titers of 32 and 4 HAU, respectively, with these same types of erythrocytes. The E2 sample showed higher sialidase activity at pH values between 5.4 and 6.6 with human erythrocytes (128-256 HAU), but the E1 sample did not exhibit significant sialidase activity with either human or chicken erythrocytes. The different pH optima for hemolysis (5.2) and sialidase (5.4-6.6) activities and the higher hemolysis indexes present in samples with sialidase activity inhibited by heating (at 56 degrees C for 30 min) or by treatment with EDTA (dilution in buffer containing 2 mM EDTA, a chelating agent on calcium-dependent sialidase activity) demonstrate the independence of these activities in the selected sample: native E2 (absorbance = 0.18), EDTA-treated native E2 (absorbance = 0.28), heated E2 (absorbance = 0.26), EDTA-treated heated E2 (absorbance = 0.41).(ABSTRACT TRUNCATED AT 250 WORDS)

Influenza virus infections in Jamaica between 1977 and 1985

Data on influenza virus infections between 1977 and 1985 in Jamaica are presented. The occurrence of influenza varied each year. The peak incidence correlated generally with the peak occurence of acute respiratory illness each year. The influenza-associated neurological (17%) and cardiac (9.7%) manifestations were seen during the perido of study. Antigenic variants of influenza viruses circulating in Jamaica were similar to those recorded world-wide. continous virological and non-virological surveillance are vital in determining the impact of influenza on associated mortality and morbidity in a developing countrylike Jamaica